Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2014 1
2020 2
2021 5
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
Coates LC, Mease P, Kronbergs A, Helt C, Sandoval D, Park SY, Combe B, Nash P, Deodhar A. Coates LC, et al. Among authors: kronbergs a. Clin Rheumatol. 2022 Oct;41(10):3035-3047. doi: 10.1007/s10067-022-06218-8. Epub 2022 Jun 8. Clin Rheumatol. 2022. PMID: 35674861 Free PMC article. Clinical Trial.
Long-term safety of Ixekizumab in adults with psoriasis, psoriatic arthritis, or axial spondyloarthritis: a post-hoc analysis of final safety data from 25 randomized clinical trials.
Deodhar A, Blauvelt A, Lebwohl M, Feely M, Kronbergs A, Eberhart N, Zhu D, Inman E, Grace E, Holzkaemper T, Rahman P, Marzo-Ortega H, Papp KA, Merola JF, Gottlieb AB, Schwartzman S. Deodhar A, et al. Among authors: kronbergs a. Arthritis Res Ther. 2024 Feb 12;26(1):49. doi: 10.1186/s13075-023-03257-7. Arthritis Res Ther. 2024. PMID: 38347650 Free PMC article.
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial.
Deodhar A, Mease P, Rahman P, Navarro-Compán V, Marzo-Ortega H, Hunter T, Sandoval D, Kronbergs A, Leon L, Shan M, Leung A, De Vlam K, Strand V. Deodhar A, et al. Among authors: kronbergs a. Rheumatol Ther. 2021 Mar;8(1):135-150. doi: 10.1007/s40744-020-00254-z. Epub 2020 Dec 7. Rheumatol Ther. 2021. PMID: 33284423 Free PMC article.
Spinal Radiographic Progression and Predictors of Progression in Patients With Radiographic Axial Spondyloarthritis Receiving Ixekizumab Over 2 Years.
van der Heijde D, Østergaard M, Reveille JD, Baraliakos X, Kronbergs A, Sandoval DM, Li X, Carlier H, Adams DH, Maksymowych WP. van der Heijde D, et al. Among authors: kronbergs a. J Rheumatol. 2022 Mar;49(3):265-273. doi: 10.3899/jrheum.210471. Epub 2021 Dec 1. J Rheumatol. 2022. PMID: 34853086 Free article.
P2Y2 receptors regulate osteoblast mechanosensitivity during fluid flow.
Gardinier J, Yang W, Madden GR, Kronbergs A, Gangadharan V, Adams E, Czymmek K, Duncan RL. Gardinier J, et al. Among authors: kronbergs a. Am J Physiol Cell Physiol. 2014 Jun 1;306(11):C1058-67. doi: 10.1152/ajpcell.00254.2013. Epub 2014 Apr 2. Am J Physiol Cell Physiol. 2014. PMID: 24696143 Free PMC article.
Correction to: Efficacy and safety of ixekizumab in patients with active psoriatic arthritis with and without concomitant conventional disease-modifying antirheumatic drugs: SPIRIT-P1 and SPIRIT-P2 3-year results.
Coates LC, Mease P, Kronbergs A, Helt C, Sandoval D, Park SY, Combe B, Nash P, Deodhar A. Coates LC, et al. Among authors: kronbergs a. Clin Rheumatol. 2022 Oct;41(10):3261. doi: 10.1007/s10067-022-06271-3. Clin Rheumatol. 2022. PMID: 35821169 Free PMC article. No abstract available.
13 results